Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Targeted therapy). Showing records 1 – 30 of 319 total matches.

[1] [2] [3] [4] [5] … [11]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters


Universiteit Utrecht

1. Tenhagen, M. FGFRs in breast cancer: expression, downstream effects and possible drug targets.

Degree: 2012, Universiteit Utrecht

 In the search of new drugs to treat cancer patients, many targeted therapies are being developed. Fibroblast growth factor receptors (FGFRs) are one of the… (more)

Subjects/Keywords: FGFR; breast cancer, targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tenhagen, M. (2012). FGFRs in breast cancer: expression, downstream effects and possible drug targets. (Masters Thesis). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/220167

Chicago Manual of Style (16th Edition):

Tenhagen, M. “FGFRs in breast cancer: expression, downstream effects and possible drug targets.” 2012. Masters Thesis, Universiteit Utrecht. Accessed January 20, 2021. http://dspace.library.uu.nl:8080/handle/1874/220167.

MLA Handbook (7th Edition):

Tenhagen, M. “FGFRs in breast cancer: expression, downstream effects and possible drug targets.” 2012. Web. 20 Jan 2021.

Vancouver:

Tenhagen M. FGFRs in breast cancer: expression, downstream effects and possible drug targets. [Internet] [Masters thesis]. Universiteit Utrecht; 2012. [cited 2021 Jan 20]. Available from: http://dspace.library.uu.nl:8080/handle/1874/220167.

Council of Science Editors:

Tenhagen M. FGFRs in breast cancer: expression, downstream effects and possible drug targets. [Masters Thesis]. Universiteit Utrecht; 2012. Available from: http://dspace.library.uu.nl:8080/handle/1874/220167


Vanderbilt University

2. Meador, Catherine Belle. Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma.

Degree: PhD, Cancer Biology, 2015, Vanderbilt University

 EGFR-mutant lung cancers are highly sensitive to EGFR tyrosine kinase inhibitors (TKIs; erlotinib/gefitinib/afatinib), but tumors develop drug resistance within 9-16 months. Resistance to gefitinib/erlotinib commonly… (more)

Subjects/Keywords: targeted therapy; EGFR; lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Meador, C. B. (2015). Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/13334

Chicago Manual of Style (16th Edition):

Meador, Catherine Belle. “Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma.” 2015. Doctoral Dissertation, Vanderbilt University. Accessed January 20, 2021. http://hdl.handle.net/1803/13334.

MLA Handbook (7th Edition):

Meador, Catherine Belle. “Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma.” 2015. Web. 20 Jan 2021.

Vancouver:

Meador CB. Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma. [Internet] [Doctoral dissertation]. Vanderbilt University; 2015. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/1803/13334.

Council of Science Editors:

Meador CB. Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma. [Doctoral Dissertation]. Vanderbilt University; 2015. Available from: http://hdl.handle.net/1803/13334


University of Melbourne

3. Corona, Silvia Paola. Targeted therapeutics in colorectal cancer.

Degree: 2013, University of Melbourne

 Colon cancer still remains the third cause of cancer related death in the western countries. Molecular targeted drugs have revolutionized the approach to cancer therapy(more)

Subjects/Keywords: colon cancer therapy; targeted therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Corona, S. P. (2013). Targeted therapeutics in colorectal cancer. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/38615

Chicago Manual of Style (16th Edition):

Corona, Silvia Paola. “Targeted therapeutics in colorectal cancer.” 2013. Doctoral Dissertation, University of Melbourne. Accessed January 20, 2021. http://hdl.handle.net/11343/38615.

MLA Handbook (7th Edition):

Corona, Silvia Paola. “Targeted therapeutics in colorectal cancer.” 2013. Web. 20 Jan 2021.

Vancouver:

Corona SP. Targeted therapeutics in colorectal cancer. [Internet] [Doctoral dissertation]. University of Melbourne; 2013. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/11343/38615.

Council of Science Editors:

Corona SP. Targeted therapeutics in colorectal cancer. [Doctoral Dissertation]. University of Melbourne; 2013. Available from: http://hdl.handle.net/11343/38615


University of New South Wales

4. Wang, Xiaochun. Overcoming resistance of targeted EGFR/panHER monotherapy by inhibition of STAT3 escape pathway in sarcoma.

Degree: Clinical School - Prince of Wales Hospital, 2014, University of New South Wales

 Sarcoma, a malignancy of mesenchymal origin, is primarily treated by surgery, augmented with chemo- and radiotherapy. The 5-year survival for metastatic sarcoma is 16%. Although… (more)

Subjects/Keywords: EGFR; Sarcoma; STAT3; Targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wang, X. (2014). Overcoming resistance of targeted EGFR/panHER monotherapy by inhibition of STAT3 escape pathway in sarcoma. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/54131 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:13255/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Wang, Xiaochun. “Overcoming resistance of targeted EGFR/panHER monotherapy by inhibition of STAT3 escape pathway in sarcoma.” 2014. Doctoral Dissertation, University of New South Wales. Accessed January 20, 2021. http://handle.unsw.edu.au/1959.4/54131 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:13255/SOURCE02?view=true.

MLA Handbook (7th Edition):

Wang, Xiaochun. “Overcoming resistance of targeted EGFR/panHER monotherapy by inhibition of STAT3 escape pathway in sarcoma.” 2014. Web. 20 Jan 2021.

Vancouver:

Wang X. Overcoming resistance of targeted EGFR/panHER monotherapy by inhibition of STAT3 escape pathway in sarcoma. [Internet] [Doctoral dissertation]. University of New South Wales; 2014. [cited 2021 Jan 20]. Available from: http://handle.unsw.edu.au/1959.4/54131 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:13255/SOURCE02?view=true.

Council of Science Editors:

Wang X. Overcoming resistance of targeted EGFR/panHER monotherapy by inhibition of STAT3 escape pathway in sarcoma. [Doctoral Dissertation]. University of New South Wales; 2014. Available from: http://handle.unsw.edu.au/1959.4/54131 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:13255/SOURCE02?view=true


University of New South Wales

5. Armstrong, Luke. Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic.

Degree: Biotechnology & Biomolecular Sciences, 2016, University of New South Wales

 Mesothelioma is a cancer of the pleural cavity in the lungs. The prognosis for people who develop this type of cancer is incredibly low, with… (more)

Subjects/Keywords: Cancer; Mesothelioma; EDV; Targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Armstrong, L. (2016). Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic. (Masters Thesis). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/56172 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:40188/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Armstrong, Luke. “Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic.” 2016. Masters Thesis, University of New South Wales. Accessed January 20, 2021. http://handle.unsw.edu.au/1959.4/56172 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:40188/SOURCE02?view=true.

MLA Handbook (7th Edition):

Armstrong, Luke. “Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic.” 2016. Web. 20 Jan 2021.

Vancouver:

Armstrong L. Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic. [Internet] [Masters thesis]. University of New South Wales; 2016. [cited 2021 Jan 20]. Available from: http://handle.unsw.edu.au/1959.4/56172 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:40188/SOURCE02?view=true.

Council of Science Editors:

Armstrong L. Studies on biomarkers of Malignant Pleural Mesothelioma to determine their value in assessing a targeted cancer therapeutic. [Masters Thesis]. University of New South Wales; 2016. Available from: http://handle.unsw.edu.au/1959.4/56172 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:40188/SOURCE02?view=true


University of New South Wales

6. Jue, Toni Rose. An Individualised Medicine Approach to Improve Survival for Patients Diagnosed with Glioblastoma.

Degree: Prince of Wales Clinical School, 2018, University of New South Wales

 Glioblastoma (GBM) is a highly aggressive primary brain tumour occurring in adults and children. The current standard treatment is maximal tumour resection followed by radiotherapy… (more)

Subjects/Keywords: Targeted therapy; Glioblastoma; Individualised medicine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jue, T. R. (2018). An Individualised Medicine Approach to Improve Survival for Patients Diagnosed with Glioblastoma. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/60204 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51073/SOURCE2?view=true

Chicago Manual of Style (16th Edition):

Jue, Toni Rose. “An Individualised Medicine Approach to Improve Survival for Patients Diagnosed with Glioblastoma.” 2018. Doctoral Dissertation, University of New South Wales. Accessed January 20, 2021. http://handle.unsw.edu.au/1959.4/60204 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51073/SOURCE2?view=true.

MLA Handbook (7th Edition):

Jue, Toni Rose. “An Individualised Medicine Approach to Improve Survival for Patients Diagnosed with Glioblastoma.” 2018. Web. 20 Jan 2021.

Vancouver:

Jue TR. An Individualised Medicine Approach to Improve Survival for Patients Diagnosed with Glioblastoma. [Internet] [Doctoral dissertation]. University of New South Wales; 2018. [cited 2021 Jan 20]. Available from: http://handle.unsw.edu.au/1959.4/60204 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51073/SOURCE2?view=true.

Council of Science Editors:

Jue TR. An Individualised Medicine Approach to Improve Survival for Patients Diagnosed with Glioblastoma. [Doctoral Dissertation]. University of New South Wales; 2018. Available from: http://handle.unsw.edu.au/1959.4/60204 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51073/SOURCE2?view=true


University of New South Wales

7. Cheung, Leanna. The isolation and characterisation of novel small molecule inhibitors of the MYCN transcriptional pathway for the potential treatment of childhood neuroblastoma.

Degree: Children's Cancer Institute Australia for Medical Research, 2011, University of New South Wales

 Neuroblastoma is the most common extracranial solid tumour in the paediatric population, and is a highly aggressive disease that originates from the precursor cells of… (more)

Subjects/Keywords: Targeted Therapy; MYCN; Neuroblastoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cheung, L. (2011). The isolation and characterisation of novel small molecule inhibitors of the MYCN transcriptional pathway for the potential treatment of childhood neuroblastoma. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/51623 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10290/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Cheung, Leanna. “The isolation and characterisation of novel small molecule inhibitors of the MYCN transcriptional pathway for the potential treatment of childhood neuroblastoma.” 2011. Doctoral Dissertation, University of New South Wales. Accessed January 20, 2021. http://handle.unsw.edu.au/1959.4/51623 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10290/SOURCE02?view=true.

MLA Handbook (7th Edition):

Cheung, Leanna. “The isolation and characterisation of novel small molecule inhibitors of the MYCN transcriptional pathway for the potential treatment of childhood neuroblastoma.” 2011. Web. 20 Jan 2021.

Vancouver:

Cheung L. The isolation and characterisation of novel small molecule inhibitors of the MYCN transcriptional pathway for the potential treatment of childhood neuroblastoma. [Internet] [Doctoral dissertation]. University of New South Wales; 2011. [cited 2021 Jan 20]. Available from: http://handle.unsw.edu.au/1959.4/51623 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10290/SOURCE02?view=true.

Council of Science Editors:

Cheung L. The isolation and characterisation of novel small molecule inhibitors of the MYCN transcriptional pathway for the potential treatment of childhood neuroblastoma. [Doctoral Dissertation]. University of New South Wales; 2011. Available from: http://handle.unsw.edu.au/1959.4/51623 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:10290/SOURCE02?view=true


University of Newcastle

8. Davey, Ryan James. Examining the expression of nucleotide excision repair genes in melanoma tumours.

Degree: PhD, 2017, University of Newcastle

Research Doctorate - Doctor of Philosophy (PhD)

Melanoma is an aggressive form of cancer characterised by poor prognosis and resistance to treatment. Despite recent advances… (more)

Subjects/Keywords: melanoma; treatment; targeted therapy; immunotherapy; combination therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Davey, R. J. (2017). Examining the expression of nucleotide excision repair genes in melanoma tumours. (Doctoral Dissertation). University of Newcastle. Retrieved from http://hdl.handle.net/1959.13/1337722

Chicago Manual of Style (16th Edition):

Davey, Ryan James. “Examining the expression of nucleotide excision repair genes in melanoma tumours.” 2017. Doctoral Dissertation, University of Newcastle. Accessed January 20, 2021. http://hdl.handle.net/1959.13/1337722.

MLA Handbook (7th Edition):

Davey, Ryan James. “Examining the expression of nucleotide excision repair genes in melanoma tumours.” 2017. Web. 20 Jan 2021.

Vancouver:

Davey RJ. Examining the expression of nucleotide excision repair genes in melanoma tumours. [Internet] [Doctoral dissertation]. University of Newcastle; 2017. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/1959.13/1337722.

Council of Science Editors:

Davey RJ. Examining the expression of nucleotide excision repair genes in melanoma tumours. [Doctoral Dissertation]. University of Newcastle; 2017. Available from: http://hdl.handle.net/1959.13/1337722


California State University – Northridge

9. Katchikian, Hurig. Unconventional approach to direct targeting of breast cancer cells.

Degree: MS, Biology, 2013, California State University – Northridge

 A superior mechanism of detecting cancerous cells and delivering anti-cancer drugs to highly localized targets is currently lacking in the field of oncology. Unfortunately, chemotherapy… (more)

Subjects/Keywords: direct targeted therapy; Dissertations, Academic  – CSUN  – Biology.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Katchikian, H. (2013). Unconventional approach to direct targeting of breast cancer cells. (Masters Thesis). California State University – Northridge. Retrieved from http://hdl.handle.net/10211.2/2545

Chicago Manual of Style (16th Edition):

Katchikian, Hurig. “Unconventional approach to direct targeting of breast cancer cells.” 2013. Masters Thesis, California State University – Northridge. Accessed January 20, 2021. http://hdl.handle.net/10211.2/2545.

MLA Handbook (7th Edition):

Katchikian, Hurig. “Unconventional approach to direct targeting of breast cancer cells.” 2013. Web. 20 Jan 2021.

Vancouver:

Katchikian H. Unconventional approach to direct targeting of breast cancer cells. [Internet] [Masters thesis]. California State University – Northridge; 2013. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/10211.2/2545.

Council of Science Editors:

Katchikian H. Unconventional approach to direct targeting of breast cancer cells. [Masters Thesis]. California State University – Northridge; 2013. Available from: http://hdl.handle.net/10211.2/2545


Vanderbilt University

10. Hutchinson, Katherine Emily. Identification of Novel Targets for Therapy in Solid Tumors.

Degree: PhD, Cancer Biology, 2015, Vanderbilt University

 Solid tumor treatment paradigms have drastically improved in recent decades through direct targeting of the protein products of somatic, constitutively active “driver” mutations and their… (more)

Subjects/Keywords: next-generation sequencing; targeted therapy; cancer; melanoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hutchinson, K. E. (2015). Identification of Novel Targets for Therapy in Solid Tumors. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/15255

Chicago Manual of Style (16th Edition):

Hutchinson, Katherine Emily. “Identification of Novel Targets for Therapy in Solid Tumors.” 2015. Doctoral Dissertation, Vanderbilt University. Accessed January 20, 2021. http://hdl.handle.net/1803/15255.

MLA Handbook (7th Edition):

Hutchinson, Katherine Emily. “Identification of Novel Targets for Therapy in Solid Tumors.” 2015. Web. 20 Jan 2021.

Vancouver:

Hutchinson KE. Identification of Novel Targets for Therapy in Solid Tumors. [Internet] [Doctoral dissertation]. Vanderbilt University; 2015. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/1803/15255.

Council of Science Editors:

Hutchinson KE. Identification of Novel Targets for Therapy in Solid Tumors. [Doctoral Dissertation]. Vanderbilt University; 2015. Available from: http://hdl.handle.net/1803/15255


Vanderbilt University

11. Nebhan, Caroline Amalia. Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma.

Degree: PhD, Cancer Biology, 2014, Vanderbilt University

 Lung cancer is the leading cause of cancer-related death in the United States and worldwide. Lung cancers that are driven by mutations in the Epidermal… (more)

Subjects/Keywords: acquired resistance; EGFR; targeted therapy; lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nebhan, C. A. (2014). Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/14054

Chicago Manual of Style (16th Edition):

Nebhan, Caroline Amalia. “Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma.” 2014. Doctoral Dissertation, Vanderbilt University. Accessed January 20, 2021. http://hdl.handle.net/1803/14054.

MLA Handbook (7th Edition):

Nebhan, Caroline Amalia. “Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma.” 2014. Web. 20 Jan 2021.

Vancouver:

Nebhan CA. Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma. [Internet] [Doctoral dissertation]. Vanderbilt University; 2014. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/1803/14054.

Council of Science Editors:

Nebhan CA. Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma. [Doctoral Dissertation]. Vanderbilt University; 2014. Available from: http://hdl.handle.net/1803/14054


McMaster University

12. Adile, Ashley Ann. Therapeutic targeting of metastatic recurrences of pediatric medulloblastoma by selective kinase and histone deacetylase inhibitors.

Degree: MSc, 2020, McMaster University

Medulloblastoma (MB) is the most common malignant pediatric brain tumour. Of its four distinct molecular subgroups (WNT, SHH, Group 3, and Group 4), Group 3… (more)

Subjects/Keywords: Medulloblastoma; Metastatic recurrence; Targeted therapy; Leptomeningeal metastasis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Adile, A. A. (2020). Therapeutic targeting of metastatic recurrences of pediatric medulloblastoma by selective kinase and histone deacetylase inhibitors. (Masters Thesis). McMaster University. Retrieved from http://hdl.handle.net/11375/25512

Chicago Manual of Style (16th Edition):

Adile, Ashley Ann. “Therapeutic targeting of metastatic recurrences of pediatric medulloblastoma by selective kinase and histone deacetylase inhibitors.” 2020. Masters Thesis, McMaster University. Accessed January 20, 2021. http://hdl.handle.net/11375/25512.

MLA Handbook (7th Edition):

Adile, Ashley Ann. “Therapeutic targeting of metastatic recurrences of pediatric medulloblastoma by selective kinase and histone deacetylase inhibitors.” 2020. Web. 20 Jan 2021.

Vancouver:

Adile AA. Therapeutic targeting of metastatic recurrences of pediatric medulloblastoma by selective kinase and histone deacetylase inhibitors. [Internet] [Masters thesis]. McMaster University; 2020. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/11375/25512.

Council of Science Editors:

Adile AA. Therapeutic targeting of metastatic recurrences of pediatric medulloblastoma by selective kinase and histone deacetylase inhibitors. [Masters Thesis]. McMaster University; 2020. Available from: http://hdl.handle.net/11375/25512


Harvard University

13. Chen, Liying Michelle. Targeting the Epigenetic Lesion in MLL-Rearranged Leukemia.

Degree: PhD, Biochemistry, 2012, Harvard University

 It has become increasingly apparent that the misregulation of histone modification actively contributes to cancer. The histone H3 lysine 79 (H3K79) methyltransferase Dot1l has been… (more)

Subjects/Keywords: Biology; DOT1L; Epigenetics; MLL; Proteomics; Targeted Therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, L. M. (2012). Targeting the Epigenetic Lesion in MLL-Rearranged Leukemia. (Doctoral Dissertation). Harvard University. Retrieved from http://nrs.harvard.edu/urn-3:HUL.InstRepos:10436226

Chicago Manual of Style (16th Edition):

Chen, Liying Michelle. “Targeting the Epigenetic Lesion in MLL-Rearranged Leukemia.” 2012. Doctoral Dissertation, Harvard University. Accessed January 20, 2021. http://nrs.harvard.edu/urn-3:HUL.InstRepos:10436226.

MLA Handbook (7th Edition):

Chen, Liying Michelle. “Targeting the Epigenetic Lesion in MLL-Rearranged Leukemia.” 2012. Web. 20 Jan 2021.

Vancouver:

Chen LM. Targeting the Epigenetic Lesion in MLL-Rearranged Leukemia. [Internet] [Doctoral dissertation]. Harvard University; 2012. [cited 2021 Jan 20]. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10436226.

Council of Science Editors:

Chen LM. Targeting the Epigenetic Lesion in MLL-Rearranged Leukemia. [Doctoral Dissertation]. Harvard University; 2012. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10436226


University of Wollongong

14. Indira Chandran, Vineesh. Development of targeted anticancer agents using novel N-alkylisatin derivatives.

Degree: Doctor of Philosophy, 2012, University of Wollongong

Targeted therapy involves selective targeting of tumour and/or tumour associated cells using agents that recognise specific biomarkers which are characteristic of the tumour cell… (more)

Subjects/Keywords: isatins; cytotoxicity; targeted therapy; ligand-drug conjugates

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Indira Chandran, V. (2012). Development of targeted anticancer agents using novel N-alkylisatin derivatives. (Doctoral Dissertation). University of Wollongong. Retrieved from 030403 Characterisation of Biological Macromolecules, 060110 Receptors and Membrane Biology, 060501 Bacteriology, 1112 ONCOLOGY AND CARCINOGENESIS ; https://ro.uow.edu.au/theses/3654

Chicago Manual of Style (16th Edition):

Indira Chandran, Vineesh. “Development of targeted anticancer agents using novel N-alkylisatin derivatives.” 2012. Doctoral Dissertation, University of Wollongong. Accessed January 20, 2021. 030403 Characterisation of Biological Macromolecules, 060110 Receptors and Membrane Biology, 060501 Bacteriology, 1112 ONCOLOGY AND CARCINOGENESIS ; https://ro.uow.edu.au/theses/3654.

MLA Handbook (7th Edition):

Indira Chandran, Vineesh. “Development of targeted anticancer agents using novel N-alkylisatin derivatives.” 2012. Web. 20 Jan 2021.

Vancouver:

Indira Chandran V. Development of targeted anticancer agents using novel N-alkylisatin derivatives. [Internet] [Doctoral dissertation]. University of Wollongong; 2012. [cited 2021 Jan 20]. Available from: 030403 Characterisation of Biological Macromolecules, 060110 Receptors and Membrane Biology, 060501 Bacteriology, 1112 ONCOLOGY AND CARCINOGENESIS ; https://ro.uow.edu.au/theses/3654.

Council of Science Editors:

Indira Chandran V. Development of targeted anticancer agents using novel N-alkylisatin derivatives. [Doctoral Dissertation]. University of Wollongong; 2012. Available from: 030403 Characterisation of Biological Macromolecules, 060110 Receptors and Membrane Biology, 060501 Bacteriology, 1112 ONCOLOGY AND CARCINOGENESIS ; https://ro.uow.edu.au/theses/3654


Uppsala University

15. Jonasson, Jennifer. Analysis of PIK3CA mutations in tumours from patients with non-small cell lung cancer using pyrosequencing.

Degree: Women's and Children's Health, 2014, Uppsala University

  A subgroup of non-small cell lung cancer (NSCLC) cases harbour mutations in classical oncogenes, which can affect therapy response and prognosis. By therapeutically targeting… (more)

Subjects/Keywords: PI3K; tumour marker; pseudogene; oncogene; targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jonasson, J. (2014). Analysis of PIK3CA mutations in tumours from patients with non-small cell lung cancer using pyrosequencing. (Thesis). Uppsala University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-227762

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Jonasson, Jennifer. “Analysis of PIK3CA mutations in tumours from patients with non-small cell lung cancer using pyrosequencing.” 2014. Thesis, Uppsala University. Accessed January 20, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-227762.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Jonasson, Jennifer. “Analysis of PIK3CA mutations in tumours from patients with non-small cell lung cancer using pyrosequencing.” 2014. Web. 20 Jan 2021.

Vancouver:

Jonasson J. Analysis of PIK3CA mutations in tumours from patients with non-small cell lung cancer using pyrosequencing. [Internet] [Thesis]. Uppsala University; 2014. [cited 2021 Jan 20]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-227762.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Jonasson J. Analysis of PIK3CA mutations in tumours from patients with non-small cell lung cancer using pyrosequencing. [Thesis]. Uppsala University; 2014. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-227762

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Debrecen

16. Lule, Andrew Kaleebu. CURRENT TREATMENTS OF METASTATIC RENAL CELL CARCINOMA .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 Renal cell carcinoma is the most common malignant tumour of the kidney approximately 85-90%.It accounts for about 2-3% of all cancers in adults. Metastatic renal… (more)

Subjects/Keywords: Cytokines Immune therapy Targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lule, A. K. (n.d.). CURRENT TREATMENTS OF METASTATIC RENAL CELL CARCINOMA . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/281199

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lule, Andrew Kaleebu. “CURRENT TREATMENTS OF METASTATIC RENAL CELL CARCINOMA .” Thesis, University of Debrecen. Accessed January 20, 2021. http://hdl.handle.net/2437/281199.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lule, Andrew Kaleebu. “CURRENT TREATMENTS OF METASTATIC RENAL CELL CARCINOMA .” Web. 20 Jan 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Lule AK. CURRENT TREATMENTS OF METASTATIC RENAL CELL CARCINOMA . [Internet] [Thesis]. University of Debrecen; [cited 2021 Jan 20]. Available from: http://hdl.handle.net/2437/281199.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Lule AK. CURRENT TREATMENTS OF METASTATIC RENAL CELL CARCINOMA . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/281199

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

17. Crispi, Manuela Vincenza. La radioterapia nell'era delle terapie biologiche: razionale delle associazioni e compliance cliniche.

Degree: 2012, Università degli Studi di Catania

 Negli ultimi vent anni si è assistito ad un acquisizione crescente delle conoscenze nel campo della biologia tumorale, frutto dell enorme sviluppo delle biotecnologie applicate… (more)

Subjects/Keywords: Area 06 - Scienze mediche; Radiation therapy, cancer, targeted therapy,tumor biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Crispi, M. V. (2012). La radioterapia nell'era delle terapie biologiche: razionale delle associazioni e compliance cliniche. (Thesis). Università degli Studi di Catania. Retrieved from http://hdl.handle.net/10761/1113

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Crispi, Manuela Vincenza. “La radioterapia nell'era delle terapie biologiche: razionale delle associazioni e compliance cliniche.” 2012. Thesis, Università degli Studi di Catania. Accessed January 20, 2021. http://hdl.handle.net/10761/1113.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Crispi, Manuela Vincenza. “La radioterapia nell'era delle terapie biologiche: razionale delle associazioni e compliance cliniche.” 2012. Web. 20 Jan 2021.

Vancouver:

Crispi MV. La radioterapia nell'era delle terapie biologiche: razionale delle associazioni e compliance cliniche. [Internet] [Thesis]. Università degli Studi di Catania; 2012. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/10761/1113.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Crispi MV. La radioterapia nell'era delle terapie biologiche: razionale delle associazioni e compliance cliniche. [Thesis]. Università degli Studi di Catania; 2012. Available from: http://hdl.handle.net/10761/1113

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Illinois – Chicago

18. Gutgesell, Lauren M. Examining the Estrogen Receptor as a Targetable Vulnerability at All Stages of ER+ Breast Cancer.

Degree: 2019, University of Illinois – Chicago

 Breast cancer is the most commonly diagnosed cancer in women, second in lethality to lung cancer. Approximately 70% of breast cancer tumors express estrogen receptor… (more)

Subjects/Keywords: Breast cancer; estrogen receptor; endocrine therapy; resistance; SERD; SERM; ShERPA; combination therapy; targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gutgesell, L. M. (2019). Examining the Estrogen Receptor as a Targetable Vulnerability at All Stages of ER+ Breast Cancer. (Thesis). University of Illinois – Chicago. Retrieved from http://hdl.handle.net/10027/23717

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gutgesell, Lauren M. “Examining the Estrogen Receptor as a Targetable Vulnerability at All Stages of ER+ Breast Cancer.” 2019. Thesis, University of Illinois – Chicago. Accessed January 20, 2021. http://hdl.handle.net/10027/23717.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gutgesell, Lauren M. “Examining the Estrogen Receptor as a Targetable Vulnerability at All Stages of ER+ Breast Cancer.” 2019. Web. 20 Jan 2021.

Vancouver:

Gutgesell LM. Examining the Estrogen Receptor as a Targetable Vulnerability at All Stages of ER+ Breast Cancer. [Internet] [Thesis]. University of Illinois – Chicago; 2019. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/10027/23717.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gutgesell LM. Examining the Estrogen Receptor as a Targetable Vulnerability at All Stages of ER+ Breast Cancer. [Thesis]. University of Illinois – Chicago; 2019. Available from: http://hdl.handle.net/10027/23717

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


NSYSU

19. Huang, Bo-cheng. To investigate the mechanism of protease-enhanced antibody activity to increase its therapeutic efficacy.

Degree: Master, Institute of Biomedical Sciences, 2014, NSYSU

 Monoclonal antibody has become clinical medicine of a variety of disease widely. According to the statistics of drug use, monoclonal antibody therapies apply to cancer,… (more)

Subjects/Keywords: Monoclonal antibody; specificity; Cancer; Autoimmune disease; Targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Huang, B. (2014). To investigate the mechanism of protease-enhanced antibody activity to increase its therapeutic efficacy. (Thesis). NSYSU. Retrieved from http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0725114-101402

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Huang, Bo-cheng. “To investigate the mechanism of protease-enhanced antibody activity to increase its therapeutic efficacy.” 2014. Thesis, NSYSU. Accessed January 20, 2021. http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0725114-101402.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Huang, Bo-cheng. “To investigate the mechanism of protease-enhanced antibody activity to increase its therapeutic efficacy.” 2014. Web. 20 Jan 2021.

Vancouver:

Huang B. To investigate the mechanism of protease-enhanced antibody activity to increase its therapeutic efficacy. [Internet] [Thesis]. NSYSU; 2014. [cited 2021 Jan 20]. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0725114-101402.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Huang B. To investigate the mechanism of protease-enhanced antibody activity to increase its therapeutic efficacy. [Thesis]. NSYSU; 2014. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0725114-101402

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universiteit Utrecht

20. Waal, L.M. de. Treatment of subtypes in non-small cell lung cancer.

Degree: 2012, Universiteit Utrecht

 Lung cancer accounts for the highest number of cancer related deaths among all cancer patients. It has been well established that exposure to tobacco significantly… (more)

Subjects/Keywords: lung cancer; treatment; targeted therapy; non-small cell lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Waal, L. M. d. (2012). Treatment of subtypes in non-small cell lung cancer. (Masters Thesis). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/241663

Chicago Manual of Style (16th Edition):

Waal, L M de. “Treatment of subtypes in non-small cell lung cancer.” 2012. Masters Thesis, Universiteit Utrecht. Accessed January 20, 2021. http://dspace.library.uu.nl:8080/handle/1874/241663.

MLA Handbook (7th Edition):

Waal, L M de. “Treatment of subtypes in non-small cell lung cancer.” 2012. Web. 20 Jan 2021.

Vancouver:

Waal LMd. Treatment of subtypes in non-small cell lung cancer. [Internet] [Masters thesis]. Universiteit Utrecht; 2012. [cited 2021 Jan 20]. Available from: http://dspace.library.uu.nl:8080/handle/1874/241663.

Council of Science Editors:

Waal LMd. Treatment of subtypes in non-small cell lung cancer. [Masters Thesis]. Universiteit Utrecht; 2012. Available from: http://dspace.library.uu.nl:8080/handle/1874/241663


University of Alberta

21. Conter, Henry J. The pharmaceutical industry’s willingness-to-sell targeted chemotherapy for incurable solid cancers.

Degree: MS, School of Public Health Sciences, 2012, University of Alberta

 How the costs of research and its associated risks contribute to a minimum price that would support continued private pharmaceutical investment is unclear. We employed… (more)

Subjects/Keywords: medical oncology; systematic review; industry; health finance; pharmacoeconomics; targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Conter, H. J. (2012). The pharmaceutical industry’s willingness-to-sell targeted chemotherapy for incurable solid cancers. (Masters Thesis). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/3b591983b

Chicago Manual of Style (16th Edition):

Conter, Henry J. “The pharmaceutical industry’s willingness-to-sell targeted chemotherapy for incurable solid cancers.” 2012. Masters Thesis, University of Alberta. Accessed January 20, 2021. https://era.library.ualberta.ca/files/3b591983b.

MLA Handbook (7th Edition):

Conter, Henry J. “The pharmaceutical industry’s willingness-to-sell targeted chemotherapy for incurable solid cancers.” 2012. Web. 20 Jan 2021.

Vancouver:

Conter HJ. The pharmaceutical industry’s willingness-to-sell targeted chemotherapy for incurable solid cancers. [Internet] [Masters thesis]. University of Alberta; 2012. [cited 2021 Jan 20]. Available from: https://era.library.ualberta.ca/files/3b591983b.

Council of Science Editors:

Conter HJ. The pharmaceutical industry’s willingness-to-sell targeted chemotherapy for incurable solid cancers. [Masters Thesis]. University of Alberta; 2012. Available from: https://era.library.ualberta.ca/files/3b591983b


Kyoto University / 京都大学

22. Nakaoku, Takashi. Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma : 浸潤性粘液肺腺がんの遺伝子異常.

Degree: 博士(医学), 2016, Kyoto University / 京都大学

リポジトリの登録にあたっては、Peer reviewされた最終版のみ可能であり、その際には下記の出版社のウェブサイトのアドレスを記載することが求められる。当該論文は2014年6月の出版であり、12ヶ月を経過していることから、公開には差し支えはない。http://clincancerres.aacrjournals.org/content/20/12/3087.full

新制・課程博士

甲第19617号

医博第4124号

Subjects/Keywords: Lung Cancer; Imvasive mucinous lung adenocarcinoma; Gene rearrangement; Targeted therapy; NRG1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nakaoku, T. (2016). Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma : 浸潤性粘液肺腺がんの遺伝子異常. (Thesis). Kyoto University / 京都大学. Retrieved from http://hdl.handle.net/2433/215443 ; http://dx.doi.org/10.14989/doctor.k19617

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Nakaoku, Takashi. “Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma : 浸潤性粘液肺腺がんの遺伝子異常.” 2016. Thesis, Kyoto University / 京都大学. Accessed January 20, 2021. http://hdl.handle.net/2433/215443 ; http://dx.doi.org/10.14989/doctor.k19617.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Nakaoku, Takashi. “Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma : 浸潤性粘液肺腺がんの遺伝子異常.” 2016. Web. 20 Jan 2021.

Vancouver:

Nakaoku T. Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma : 浸潤性粘液肺腺がんの遺伝子異常. [Internet] [Thesis]. Kyoto University / 京都大学; 2016. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/2433/215443 ; http://dx.doi.org/10.14989/doctor.k19617.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Nakaoku T. Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma : 浸潤性粘液肺腺がんの遺伝子異常. [Thesis]. Kyoto University / 京都大学; 2016. Available from: http://hdl.handle.net/2433/215443 ; http://dx.doi.org/10.14989/doctor.k19617

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

23. Favrot, Clémentine. Développement d’une thérapie ciblée anticancéreuse dirigée contre le couple SEMA3E/PLXND1 : Development of a targeted ant-cancer therapy against Sema3E/PlxnD1.

Degree: Docteur es, Cancérologie, 2017, Lyon

Les protéines Sémaphorines et leurs récepteurs Plexines jouent un rôle primordial dans le réseau de signalisation cellulaire. Initialement découvertes pour leur rôle dans le guidage… (more)

Subjects/Keywords: Sema3E; PlxnD1; Thérapie ciblée; Sema3E; PlxnD1; Targeted therapy; 616.99

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Favrot, C. (2017). Développement d’une thérapie ciblée anticancéreuse dirigée contre le couple SEMA3E/PLXND1 : Development of a targeted ant-cancer therapy against Sema3E/PlxnD1. (Doctoral Dissertation). Lyon. Retrieved from http://www.theses.fr/2017LYSE1094

Chicago Manual of Style (16th Edition):

Favrot, Clémentine. “Développement d’une thérapie ciblée anticancéreuse dirigée contre le couple SEMA3E/PLXND1 : Development of a targeted ant-cancer therapy against Sema3E/PlxnD1.” 2017. Doctoral Dissertation, Lyon. Accessed January 20, 2021. http://www.theses.fr/2017LYSE1094.

MLA Handbook (7th Edition):

Favrot, Clémentine. “Développement d’une thérapie ciblée anticancéreuse dirigée contre le couple SEMA3E/PLXND1 : Development of a targeted ant-cancer therapy against Sema3E/PlxnD1.” 2017. Web. 20 Jan 2021.

Vancouver:

Favrot C. Développement d’une thérapie ciblée anticancéreuse dirigée contre le couple SEMA3E/PLXND1 : Development of a targeted ant-cancer therapy against Sema3E/PlxnD1. [Internet] [Doctoral dissertation]. Lyon; 2017. [cited 2021 Jan 20]. Available from: http://www.theses.fr/2017LYSE1094.

Council of Science Editors:

Favrot C. Développement d’une thérapie ciblée anticancéreuse dirigée contre le couple SEMA3E/PLXND1 : Development of a targeted ant-cancer therapy against Sema3E/PlxnD1. [Doctoral Dissertation]. Lyon; 2017. Available from: http://www.theses.fr/2017LYSE1094


University of Louisville

24. Karukonda, Divya. Advances in tumor-targeted therapy using nanomedicine.

Degree: MS, 2017, University of Louisville

  Despite continuous improvement and significant progress made in diagnostic and therapeutic approaches for cancer, it is still the leading cause of death worldwide. Although… (more)

Subjects/Keywords: cancer; nanomedicine; targeted therapy; exosome; Pharmacology, Toxicology and Environmental Health

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Karukonda, D. (2017). Advances in tumor-targeted therapy using nanomedicine. (Masters Thesis). University of Louisville. Retrieved from 10.18297/etd/2800 ; https://ir.library.louisville.edu/etd/2800

Chicago Manual of Style (16th Edition):

Karukonda, Divya. “Advances in tumor-targeted therapy using nanomedicine.” 2017. Masters Thesis, University of Louisville. Accessed January 20, 2021. 10.18297/etd/2800 ; https://ir.library.louisville.edu/etd/2800.

MLA Handbook (7th Edition):

Karukonda, Divya. “Advances in tumor-targeted therapy using nanomedicine.” 2017. Web. 20 Jan 2021.

Vancouver:

Karukonda D. Advances in tumor-targeted therapy using nanomedicine. [Internet] [Masters thesis]. University of Louisville; 2017. [cited 2021 Jan 20]. Available from: 10.18297/etd/2800 ; https://ir.library.louisville.edu/etd/2800.

Council of Science Editors:

Karukonda D. Advances in tumor-targeted therapy using nanomedicine. [Masters Thesis]. University of Louisville; 2017. Available from: 10.18297/etd/2800 ; https://ir.library.louisville.edu/etd/2800


Vanderbilt University

25. Doxie, Deon Bryant. Quantitative Single Cell Analysis of Cancerous Cells During Therapy.

Degree: PhD, Cell and Developmental Biology, 2018, Vanderbilt University

 Single cell tools have great potential to characterize mechanisms of oncogenesis and treatment resistance. To date, single cell quantitative cytometry has been widely applied in… (more)

Subjects/Keywords: single cell; solid tumor; targeted therapy; melanoma; mass cytometry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Doxie, D. B. (2018). Quantitative Single Cell Analysis of Cancerous Cells During Therapy. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/12624

Chicago Manual of Style (16th Edition):

Doxie, Deon Bryant. “Quantitative Single Cell Analysis of Cancerous Cells During Therapy.” 2018. Doctoral Dissertation, Vanderbilt University. Accessed January 20, 2021. http://hdl.handle.net/1803/12624.

MLA Handbook (7th Edition):

Doxie, Deon Bryant. “Quantitative Single Cell Analysis of Cancerous Cells During Therapy.” 2018. Web. 20 Jan 2021.

Vancouver:

Doxie DB. Quantitative Single Cell Analysis of Cancerous Cells During Therapy. [Internet] [Doctoral dissertation]. Vanderbilt University; 2018. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/1803/12624.

Council of Science Editors:

Doxie DB. Quantitative Single Cell Analysis of Cancerous Cells During Therapy. [Doctoral Dissertation]. Vanderbilt University; 2018. Available from: http://hdl.handle.net/1803/12624


Vanderbilt University

26. Paudel, Buddhi Bishal. Understanding Drug Response Dynamics in BRAF-mutated Melanoma Cells.

Degree: PhD, Chemical and Physical Biology, 2018, Vanderbilt University

Targeted therapy is an effective standard of care in BRAF-mutated malignant melanoma. However, tumor remission varies unpredictably among patients and relapse is almost inevitable. Surprisingly,… (more)

Subjects/Keywords: Melanoma; Mathematical Modeling; Targeted Therapy; Drug Response; Dynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Paudel, B. B. (2018). Understanding Drug Response Dynamics in BRAF-mutated Melanoma Cells. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/14712

Chicago Manual of Style (16th Edition):

Paudel, Buddhi Bishal. “Understanding Drug Response Dynamics in BRAF-mutated Melanoma Cells.” 2018. Doctoral Dissertation, Vanderbilt University. Accessed January 20, 2021. http://hdl.handle.net/1803/14712.

MLA Handbook (7th Edition):

Paudel, Buddhi Bishal. “Understanding Drug Response Dynamics in BRAF-mutated Melanoma Cells.” 2018. Web. 20 Jan 2021.

Vancouver:

Paudel BB. Understanding Drug Response Dynamics in BRAF-mutated Melanoma Cells. [Internet] [Doctoral dissertation]. Vanderbilt University; 2018. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/1803/14712.

Council of Science Editors:

Paudel BB. Understanding Drug Response Dynamics in BRAF-mutated Melanoma Cells. [Doctoral Dissertation]. Vanderbilt University; 2018. Available from: http://hdl.handle.net/1803/14712


University of Oxford

27. Skaripa-Koukelli, Eirini. Towards the synthesis and delivery of a halogenated MCT1 substrate.

Degree: PhD, 2020, University of Oxford

 The monocarboxylate transporter 1 (MCT1) has received special attention as a potential therapeutic target in cancer thanks to its role in lactate shuttling. In breast… (more)

Subjects/Keywords: Drug delivery systems; tumour metabolism; targeted radionuclide therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Skaripa-Koukelli, E. (2020). Towards the synthesis and delivery of a halogenated MCT1 substrate. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:644745d6-9ce1-4039-a6fa-6f46196c3c8f ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.808306

Chicago Manual of Style (16th Edition):

Skaripa-Koukelli, Eirini. “Towards the synthesis and delivery of a halogenated MCT1 substrate.” 2020. Doctoral Dissertation, University of Oxford. Accessed January 20, 2021. http://ora.ox.ac.uk/objects/uuid:644745d6-9ce1-4039-a6fa-6f46196c3c8f ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.808306.

MLA Handbook (7th Edition):

Skaripa-Koukelli, Eirini. “Towards the synthesis and delivery of a halogenated MCT1 substrate.” 2020. Web. 20 Jan 2021.

Vancouver:

Skaripa-Koukelli E. Towards the synthesis and delivery of a halogenated MCT1 substrate. [Internet] [Doctoral dissertation]. University of Oxford; 2020. [cited 2021 Jan 20]. Available from: http://ora.ox.ac.uk/objects/uuid:644745d6-9ce1-4039-a6fa-6f46196c3c8f ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.808306.

Council of Science Editors:

Skaripa-Koukelli E. Towards the synthesis and delivery of a halogenated MCT1 substrate. [Doctoral Dissertation]. University of Oxford; 2020. Available from: http://ora.ox.ac.uk/objects/uuid:644745d6-9ce1-4039-a6fa-6f46196c3c8f ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.808306


Texas A&M University

28. Hamoui, Zaher Basel. In Vitro Cytotoxicity of 198Au-NPs Labeled HIV-1 Tat CPP for the Treatment of Metastatic Breast Cancer.

Degree: MS, Nuclear Engineering, 2015, Texas A&M University

 The present research advances the area of targeted radionuclide therapy (TRT) by using nanoparticles as intrinsic carriers of radionuclides. In here we proposed the use… (more)

Subjects/Keywords: Nuclear Nanotechnology; Targeted Radionuclide Therapy Nanotechnology; Metastatic Cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hamoui, Z. B. (2015). In Vitro Cytotoxicity of 198Au-NPs Labeled HIV-1 Tat CPP for the Treatment of Metastatic Breast Cancer. (Masters Thesis). Texas A&M University. Retrieved from http://hdl.handle.net/1969.1/156248

Chicago Manual of Style (16th Edition):

Hamoui, Zaher Basel. “In Vitro Cytotoxicity of 198Au-NPs Labeled HIV-1 Tat CPP for the Treatment of Metastatic Breast Cancer.” 2015. Masters Thesis, Texas A&M University. Accessed January 20, 2021. http://hdl.handle.net/1969.1/156248.

MLA Handbook (7th Edition):

Hamoui, Zaher Basel. “In Vitro Cytotoxicity of 198Au-NPs Labeled HIV-1 Tat CPP for the Treatment of Metastatic Breast Cancer.” 2015. Web. 20 Jan 2021.

Vancouver:

Hamoui ZB. In Vitro Cytotoxicity of 198Au-NPs Labeled HIV-1 Tat CPP for the Treatment of Metastatic Breast Cancer. [Internet] [Masters thesis]. Texas A&M University; 2015. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/1969.1/156248.

Council of Science Editors:

Hamoui ZB. In Vitro Cytotoxicity of 198Au-NPs Labeled HIV-1 Tat CPP for the Treatment of Metastatic Breast Cancer. [Masters Thesis]. Texas A&M University; 2015. Available from: http://hdl.handle.net/1969.1/156248


University of Toronto

29. Jessa, Fatima. In Vitro Analysis of ER Maleate as a Novel Anticancer Agent for Oral Cancer.

Degree: 2016, University of Toronto

A high throughput chemical screen identified ER maleate as a potential anticancer agent for oral squamous cell carcinoma (OSCC). ER maleate treatment of OSCC cell… (more)

Subjects/Keywords: Biomarkers; Molecular-targeted therapy; Oral Cancer; Pathology; Treatment; 0564

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jessa, F. (2016). In Vitro Analysis of ER Maleate as a Novel Anticancer Agent for Oral Cancer. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/74750

Chicago Manual of Style (16th Edition):

Jessa, Fatima. “In Vitro Analysis of ER Maleate as a Novel Anticancer Agent for Oral Cancer.” 2016. Masters Thesis, University of Toronto. Accessed January 20, 2021. http://hdl.handle.net/1807/74750.

MLA Handbook (7th Edition):

Jessa, Fatima. “In Vitro Analysis of ER Maleate as a Novel Anticancer Agent for Oral Cancer.” 2016. Web. 20 Jan 2021.

Vancouver:

Jessa F. In Vitro Analysis of ER Maleate as a Novel Anticancer Agent for Oral Cancer. [Internet] [Masters thesis]. University of Toronto; 2016. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/1807/74750.

Council of Science Editors:

Jessa F. In Vitro Analysis of ER Maleate as a Novel Anticancer Agent for Oral Cancer. [Masters Thesis]. University of Toronto; 2016. Available from: http://hdl.handle.net/1807/74750


University of Toronto

30. Chan, Dianna. Polymeric Micelles for SiRNA and AON Delivery.

Degree: 2012, University of Toronto

Immuno-nanoparticles of poly(ᴅ,ʟ-lactide-co-2-methyl-2-carboxytrimethylene carbonate)-g-poly(ethylene glycol) (poly(LA-co-TMCC)-g-PEG) have been used to target breast cancer cells through the specific binding of trastuzumab antibodies to over-expressed human epidermal… (more)

Subjects/Keywords: polymer nanoparticles; targeted delivery; gene therapy; drug delivery; 0542

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chan, D. (2012). Polymeric Micelles for SiRNA and AON Delivery. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/33368

Chicago Manual of Style (16th Edition):

Chan, Dianna. “Polymeric Micelles for SiRNA and AON Delivery.” 2012. Masters Thesis, University of Toronto. Accessed January 20, 2021. http://hdl.handle.net/1807/33368.

MLA Handbook (7th Edition):

Chan, Dianna. “Polymeric Micelles for SiRNA and AON Delivery.” 2012. Web. 20 Jan 2021.

Vancouver:

Chan D. Polymeric Micelles for SiRNA and AON Delivery. [Internet] [Masters thesis]. University of Toronto; 2012. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/1807/33368.

Council of Science Editors:

Chan D. Polymeric Micelles for SiRNA and AON Delivery. [Masters Thesis]. University of Toronto; 2012. Available from: http://hdl.handle.net/1807/33368

[1] [2] [3] [4] [5] … [11]

.